Web-based TAVR marketing found to overstate benefits, understate risks of procedure
Monday, January 12, 2015 - 16:30
in Health & Medicine
Transcatheter aortic valve replacement, or TAVR, has been called one of the biggest advances in cardiac surgery in recent years. The procedure delivers a new, collapsible aortic valve through a catheter to the valve site within the heart - a repair that otherwise requires open heart surgery. While a boon for many patients who would not have been a candidate for conventional surgery, researchers have discovered that marketing for TAVR does not accurately portray the risks associated with undergoing the procedure.